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Abstract
Objective We examined the associations between sweets,
sweetened and unsweetened beverages, and sugars and
pancreatic cancer risk.
Methods We conducted a population-based case–control
study (532 cases, 1,701 controls) and used multivariate
logistic regression models to calculate odds ratios (OR) and
95% confidence intervals (CI). Because associations were
often different by sex, we present results for men and
women combined and separately.
Results Among men, greater intakes of total and specific
sweets were associated with pancreatic cancer risk (total
sweets: OR = 1.9, 95% CI: 1.0, 3.6; sweet condiments:
OR = 1.9, 95% CI: 1.2, 3.1; chocolate candy: OR = 2.4,
95% CI: 1.1, 5.0; other mixed candy bars: OR = 3.3, 95%
CI: 1.5, 7.3 for 1 ? servings/day versus none/rarely).
Sweets were not consistently associated with risk among
women. Sweetened beverages were not associated with
increased pancreatic cancer risk. In contrast, low-calorie
soft drinks were associated with increased risk among men
only; while other low-/non-caloric beverages (e.g., coffee,
tea, and water) were unassociated with risk. Of the three
sugars assessed (lactose, fructose, and sucrose), only the
milk sugar lactose was associated with pancreatic cancer
risk (OR = 2.0, 95% CI: 1.5, 2.7 comparing extreme
quartiles).
Conclusion These results provide limited support for the
hypothesis that sweets or sugars increase pancreatic cancer
risk.
Keywords Pancreatic cancer  Epidemiology 
Sweets  Beverages
Introduction
Pancreatic cancer is the fourth leading cause of cancer
death among men and women in the United States and the
most fatal cancer. A number of 37,680 individuals were
estimated to have been diagnosed with pancreatic cancer
and 34,290 people were expected to die of the disease in
2008 [1]. Greater age, cigarette smoking, and male sex are
fairly well-established risk factors for this deadly cancer.
Diabetes also has been linked to greater risk of pancreatic
cancer, and meta-analyses suggest that this link may be
causal, or at least that metabolic conditions predisposing to
diabetes precede pancreatic cancer [2, 3]. Four prospective
studies that examined banked serum have linked higher
fasting glucose levels with subsequent risk of pancreatic
cancer several years later [4–7], and pre-diagnostic plasma
C-peptide levels have been linked to greater risk of pan-
creatic cancer [8]. In vitro, insulin increases pancreatic
cancer cell proliferation in a dose-dependent manner [9].
Hyperglycemia, insulin insensitivity, and hyperinsulinemia
can lead to very high insulin exposure of the exocrine
pancreatic cells, and this may play a role in pancreatic
cancer development [4, 9].
Accordingly, it has been of interest to investigate dietary
practices that may predispose to diabetes, hyperglycemia,
or hyperinsulinemia. We examined sweets, sweetened
beverages, and sugars as risk factors for pancreatic cancer
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in a large population-based case–control study. For com-
parison, we examined artificially sweetened, low-calorie,
or non-caloric beverages (e.g., diet soft drinks, water, tea,
and coffee) and pancreatic cancer risk. We hypothesized
that intake of sweets, sugar, and beverages with sugar
would be associated with an elevated risk of pancreatic
cancer, based on their possible positive correlation with
hyperglycemia and hyperinsulinemia; while artificially
sweetened or low-calorie beverages would be unassociated
with risk given their lesser effect on insulin response.
Materials and methods
Study population
Details of this study have been published previously [10–
23]. Briefly, between 1995 and 1999, men and women with
incident adenocarcinoma of the exocrine pancreas were
identified in six counties of the San Francisco Bay Area
(in-area cases) using rapid case ascertainment operated by
the Northern California Cancer Center. Pancreatic cancer
diagnoses were confirmed by contacting the participants’
physicians and using Surveillance, Epidemiology, and End
Results (SEER) abstracts. Eligible in-area cases were 21–
85 years of age, residents of one of the six counties, alive
upon first contact, and could complete an in-person inter-
view in English. Sixty-five eligible out-of-area cases also
were interviewed. They were seen in the University of
California San Francisco clinics and met the same criteria
as in-area cases except that most were residents of counties
adjacent to the six Bay Area counties. Of 798 eligible
cases, 532 (67%) completed an interview for this study and
8% refused to participate. The main reason the remaining
eligible cases did not participate was because they died
prior to contact. Control participants were frequency-mat-
ched to cases by sex and age within five-year categories
and were selected from the target population using random
digit dial. Controls older than 65 years were supplemented
by random selection from Health Care Finance Adminis-
tration lists (now the Centers for Medicare & Medicaid
Services). Of 2,525 eligible controls, 1,701 (67%) com-
pleted an interview for this study. No proxy interviews
were conducted. This study was reviewed and approved by
the University of California San Francisco Institutional
Review Board and written informed consent was obtained
from all the participants prior to interview.
Assessment of intake of sweets and non-alcoholic
beverages
Participants reported, via in-person interviews, their fre-
quency of intake of individual food items that were listed on
a 131-item food questionnaire for the time period of one
year before their cancer diagnosis for cases, or interview for
controls. Intake of seasonal food was averaged throughout
the entire year. This semi-quantitative food-frequency
questionnaire was obtained from the Harvard University,
has been validated in a variety of populations [24–26], and
is considered to perform similarly to the National Cancer
Institute Diet History Questionnaire and the Block food-
frequency questionnaire [26]. In a validation study from the
Nurses Health Study, the correlation coefficients between
questionnaire and diet record responses for several of the
sweet and beverage items of interest were: chocolate 0.41,
sweets 0.63, coffee 0.77, tea 0.86, coke/pepsi 0.84, and non-
cola carbonated beverages 0.40 [27].
The specified portion size of each food item was con-
sidered as one serving, and the food frequency responses
were transformed into servings per day. The options for
frequency of food intake were: never, \1/month (rarely),
1–3/month, 1/week, 2–4/week, 5–6/week, 1/day, 2–3/day,
4–5/day, and 6?/day. Consumption of total and individual
sweets and beverage items was examined. Sweets included
pure chocolate candy bars or packets of candy (e.g.,
M&Ms), other mixed candy bars (e.g., Snickers/Milky
Way/Reeses), candy without chocolate (e.g., mints, life-
savers), and sweet condiments (i.e., jams/jellies/preserves/
syrup/honey). Total carbonated beverages included those
with sugar (i.e., Coke/Pepsi/other colas, caffeine-free Coke/
Pepsi/other colas, and other) and sugar-free types (i.e., low-
calorie colas, low-calorie caffeine-free colas, and other low-
calorie carbonated beverages such as diet 7-up, Fresca, diet
ginger ale, etc.). Other sweetened beverages assessed
included punch/lemonade/non-carbonated fruit drinks (not
juice). Other non-caloric or low-calorie beverages assessed
for comparison included plain water, herbal tea, non-herbal
tea, decaffeinated coffee, and caffeinated coffee. While we
did not have specific information regarding sugar added to
tea or coffee, we were able to examine overall teaspoons of
sugar added to food or beverages. The range of the corre-
lation coefficients among all of the sweets was 0.09–0.41.
The strongest correlation was observed between pure
chocolate candy bars or packets of candy and other mixed
candy bars, and the weakest association was found between
sweet condiments and candy without chocolate. The range
of the correlation coefficients among all of the beverages
was 0.00–0.32. The strongest correlations were observed for
items such as Coke/Pepsi/other colas with sugar and other
carbonated beverages (correlation coefficient = 0.32) and
low-calorie colas with other low-calorie carbonated bever-
ages (correlation coefficient = 0.24).
The completed food frequency questionnaires were sent
to the Harvard School of Public Health, Department of
Nutrition for assessment of nutrient intake using their
previously published methods [28]. Of interest to this
836 Cancer Causes Control (2009) 20:835–846
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report, nutrients assessed included total calories, and three
sugars—fructose, sucrose, and lactose. These were exam-
ined in quartiles based on control group cut-points.
Statistical methods
Odds ratios (OR) and 95% confidence intervals (CI) were
computed using unconditional logistic regression to esti-
mate the relative risk (hereafter called risk) of pancreatic
cancer. No substantial difference in ORs was observed
when we included or excluded study participants
with extremely low (\500 kcal/day) or extremely high
([3,500 kcal/day) caloric intake, and these participants
were retained in the final analyses. The linear trend test was
performed using the Wald procedure. Potential confounding
effects were investigated for total calories, sex, body-mass
index (BMI), cigarette smoking, race, education, history of
diabetes, physical activity, and other food groups. Total
caloric intake was divided into quartiles based on the con-
sumption among control participants by sex (cutpoints:
men: B1,545; 1,546–1,925; 1,926–2,364; C2,365 kcal/day;
women: B1,333; 1,334–1,695; 1,696–2,113; C2,114 kcal/
day). BMI was categorized as \25 (normal), 25.0–29.9
(overweight), and C30 (obese) kg/m2, based on the World
Health Organization criteria. Smokers were defined as
participants who had smoked [100 cigarettes in their life-
time, or a pipe or cigar for at least once a month for
C6 months. Participants were classified as: never smokers;
former cigarette smokers who quit smoking [15 years
ago; former cigarette smokers who quit smoking 1–15 years
ago; former smokers who quit within one year prior to
diagnosis or to interview, and current cigarette smokers;
and pipe and/or cigar smokers. Participants provided self-
reported data on race (white, black or African American,
Asian or Pacific Islander, or ‘‘other’’); education (\high-
school graduate, high-school graduate, 1–4 years college,
and graduate work); history of diabetes (yes/no); and fre-
quency of non-occupational physical activity (i.e., 30 min
intervals performed B1/month, 2–4/month, 2–6/week, or
1?/day). We also considered intake of other food groups in
quartiles based on previous publications from this popula-
tion (i.e., red meat, white meat, dairy, vegetable and fruit,
eggs, fish, whole grain, and refined grain) [11, 19, 20].
Stepwise logistic regression modeling (using p = 0.05)
was used to determine the variables that provided the best-
fit among the potentially confounding factors. By these
criteria, only total energy appeared to confound the rela-
tionships between sweets and beverages and pancreatic
cancer risk. For comparability with other studies and our
previous publications, we first present a parsimonious
model in the tables that was adjusted for the matching
factors of age and sex, and for total energy intake. We then
present a full multivariable model additionally adjusted for
the following putative confounding factors: BMI, smoking
status, race, education, history of diabetes, physical activ-
ity, and other food groups. Adjustment for other food
groups included mutual adjustment for all sweet and bev-
erage risk factors of interest plus previously examined food
groups [11, 19, 20] (e.g., total sweets were adjusted for all
sweetened and unsweetened beverage intake, as well as
consumption of red meat, white meat, vegetables and fruits,
eggs, fish, dairy, whole grains, and refined grains). The
results for men and women are presented combined and
separately. Because there was little difference between the
parsimonious model and the fully adjusted model, we
present only the full model for the results stratified by sex.
To further consider the effects of confounding or effect
modification on these results, we examined total sweets and
carbonated beverages (with or without sugar) in multivar-
iable models within strata of BMI (normal, overweight, and
obese), exercise (monthly vs. daily exercisers), diabetes
(yes/no), and smoking history (current, former, never). We
considered stratifying BMI further, however, limited
numbers made this infeasible (e.g., BMI C 35: n = 13
cases/31 controls; BMI C 40: n = 3 cases/6 controls).
All statistical tests were two-sided and considered sta-
tistically significant when p \ 0.05. Statistical analyses
were conducted using SAS software 9.1 (SAS Institute,
Inc., Cary, NC).
Results
Demographic and other factors in this large population-
based case–control study are presented in Table 1. Cases
and controls were similar with regards to race, BMI, and
history of diabetes; and the majority of participants were
non-Hispanic whites. Cases were more likely to have a
recent smoking history than controls, whereas controls
were slightly more educated than cases.
There was some evidence for positive associations
between consumption of total and individual sweets and
risk of pancreatic cancer among men (for comparisons of
1? servings/day versus rarely or never, total sweets
OR = 1.9, 95% CI: 1.0, 3.6; sweet condiments OR = 1.9,
95% CI: 1.2, 3.1; chocolate candy OR = 2.4, 95% CI: 1.1,
5.0; other mixed candy bars OR = 3.3, 95% CI: 1.5, 7.3)
(Table 2). Among women, there was overall less support
for any association with total or individual sweets, although
there was a positive trend for sweet condiments (Table 2).
Candy without chocolate was unassociated with risk of
pancreatic cancer.
To further examine the impact of foods high in sugar, we
examined sweetened beverages and the risk of pancreatic
cancer (Table 3). Overall, total sweetened beverages,
including sugar-based sodas, colas, and non-carbonated fruit
Cancer Causes Control (2009) 20:835–846 837
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drinks were unassociated with risk of pancreatic cancer.
Among women, the highest versus lowest intake of punch/
lemonade/non-carbonated fruit drinks was associated with a
borderline statistically significant doubling in risk, but
intermediate intake categories were inversely associated
with risk. In contrast, some, but not all, low-calorie car-
bonated drinks were linked to about a 50–80% higher risk of
pancreatic cancer when comparing consumption of 1?
servings/day versus rarely. These relationships were only
statistically significant among men when we examined
associations stratified by sex (sugar-free carbonated bever-
ages OR = 1.8, 95% CI: 1.1, 2.8; low-calorie cola
OR = 1.8, 95% CI: 1.1, 2.9).
For further comparison, we examined other low- or non-
caloric beverages and risk of pancreatic cancer. Coffee
(with or without caffeine), herbal tea, and water were not
associated with risk of pancreatic cancer among men,
women, or both sexes combined. Non-herbal tea was not
associated with risk among women, but there was a posi-
tive trend among men only (OR = 1.6, 95% CI 1.1, 2.2 for
1? servings/day versus \1/month; p-value trend = 0.02).
Teaspoons of sugar or artificial sweeteners added to foods
or beverages was also unassociated with risk of pancreatic
cancer (multivariate OR = 0.7, 95% CI: 0.5, 1.1 for C3 vs.
0 teaspoons of sugar per day; multivariate OR = 1.3, 95%
CI 0.8-1.9 for C1 packet sweetener vs. none per day;
adjusted for age sex, calories, BMI, race, education,
smoking, diabetes, and exercise).
In order to further consider the effects of confounding
or effect modification on these results, we examined total
sweets and carbonated beverages in multivariable models
within strata of BMI, exercise, diabetes, and smoking
history (data not shown in tables). There was some sug-
gestion that the positive association for total sweets was
stronger or limited to those who were obese, infrequent
exercisers, or current smokers; although, with the smaller
numbers in the finer categories, results were not statisti-
cally significant. When comparing consumption of 1?
servings/day of total sweets versus none, the risks of
pancreatic cancer across strata of BMI were: obese,
OR = 3.2, 95% CI: 0.7, 15; overweight, OR = 1.1, 95%
CI: 0.5, 2.4; and normal, OR = 1.2, 95% CI: 0.7, 2.1.
Similarly, across categories of smoking, the odds ratios of
pancreatic cancer for 1? servings/day of total sweets
versus none were: current smoker, OR = 1.8, 95% CI: 0.6,
5.4; former smoker, OR = 1.2, 95% CI: 0.5, 2.9; and never
smoker, OR = 1.1, 95% CI: 0.6, 2.4. Lastly, for the same
comparison by exercise the odds ratios were: infrequent
exercise, OR = 2.0, 95% CI: 1.0, 4.0 for and daily exer-
cisers, OR = 1.0, 95% CI: 0.3, 2.7. The previously
observed elevated risk for sugar-free carbonated beverages
also appeared to be limited to those who were obese
(obese, OR = 2.6, 95% CI: 0.9, 7.7; overweight,
OR = 1.5, 95% CI: 0.9, 2.6; and normal BMI, OR = 1.3,
95% CI: 0.8, 2.1), did not have diabetes (no diabetes,
OR = 1.6, 95% CI: 1.1, 2.3; yes diabetes, OR = 0.9, 95%
Table 1 Demographic characteristics of pancreatic cancer patients
and control participants in a population-based case–control study in
the San Francisco Bay Area, California
Characteristic Cases
(N = 532)
Controls
(N = 1,701)
n % n %
Agea, years
\50 46 9 164 10
50–59 120 22 438 25
60–69 172 33 473 28
70–79 158 39 498 30
80–85 36 7 128 8
Sex
Men 291 55 883 52
Women 241 45 818 48
Race
White 442 83 1,471 86
Black or African American 46 9 78 5
Asian or Pacific Islander 35 7 119 7
American Indian or Alaskan
Native or other
9 2 33 2
Hispanic ethnicity
Yes 25 5 114 7
No 507 95 1,585 93
Body mass index (WHO), kg/m2
Normal, \25.0 280 53 993 58
Overweight, 25.0–29.9 197 37 552 33
Obese, C30 52 10 147 9
Smoking
Never 163 31 652 38
Cigarette
Former, quit [15 years ago 133 25 508 30
Former, quit 1–15 years ago 89 17 260 15
Current or quit \1 year ago 131 25 208 12
Pipe/cigar 16 3 73 4
Education
\High-school graduate 71 13 162 10
High-school graduate 164 31 372 22
1–4 years college 200 38 754 44
Graduate school 97 18 413 24
History of diabetes mellitus
No 455 86 1,538 90
Yes 76 11 161 10
Numbers may not add to total number of participants due to missing
values
a Age at pancreatic cancer diagnosis for cases or age at interview for
controls
838 Cancer Causes Control (2009) 20:835–846
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CI: 0.3, 2.6), or were current smokers (current, OR = 2.6,
95% CI: 1.1, 5.9; former, OR = 0.5, 95% CI: 0.2, 1.3;
never, OR = 0.8, 95% CI: 0.4, 1.5).
We examined the risk of pancreatic cancer associated
with intake of the sugars fructose, sucrose, and lactose
(Table 4). Of these, only lactose was associated with an
elevated risk of pancreatic cancer when comparing extreme
quartiles. To address the possibility that this result for
lactose (found in milk products) may have been con-
founded by fat intake, we further adjusted for total fat
intake and results were similar (combined: OR = 2.0, 95%
CI: 1.5, 2.7, p \ 0.0001; men: OR = 2.1, 95% CI: 1.3, 3.0,
p = 0.003; women: OR = 1.7, 95% CI: 1.1, 2.7, p = 0.03,
when comparing extreme quartiles, Table 4).
Discussion
These results provide limited evidence for our original
hypothesis that sweets and sweetened beverages would be
positively associated with risk of pancreatic cancer,
although results varied by sex. Total sweets and specific
Table 2 Odds ratios (OR) and 95% confidence intervals (CI) for pancreatic cancer and consumption of sweets in a population-based case–
control study, San Francisco Bay Area, California
Men ? Women Men Women
Sweets (1 serving) Case n % Control n % ORa 95% CIa ORb 95% CIb ORb 95% CIb ORb 95% CIb
Total sweets, servings/day
0 54 10 183 11 1.0 Ref 1.0 Ref 1.0 Ref 1.0 Ref
\1 316 60 1,156 68 0.8 0.6, 1.2 0.9 0.6, 1.3 1.2 0.7, 2.2 0.6 0.4, 1.1
C1 156 30 362 21 1.2 0.8, 1.8 1.3 0.8, 1.9 1.9 1.0, 3.6 0.8 0.4, 1.4
Trend-p 0.3 0.1 0.01 0.5
Sweet condiments (1 tablespoon)
\1/month 106 20 428 25 1.0 Ref 1.0 Ref 1.0 Ref 1.0 Ref
1–3/month 82 16 364 21 0.9 0.6, 1.2 0.9 0.6, 1.2 1.1 0.7, 1.7 0.8 0.5, 1.3
1–6/week 254 48 696 41 1.3 1.0, 1.7 1.5 1.1, 1.9 1.6 1.1, 2.4 1.5 1.0, 2.2
C1/day 84 16 212 13 1.4 1.0, 2.0 1.6 1.1, 2.3 1.9 1.2, 3.1 1.5 0.9, 2.6
Trend-p 0.007 0.0004 0.002 0.02
Pure chocolate candy bar or packet (1)
\1/month 245 47 863 51 1.0 Ref 1.0 Ref 1.0 Ref 1.0 Ref
1–3/month 131 25 439 26 1.0 0.8, 1.3 1.1 0.8, 1.4 1.3 0.9, 1.9 0.9 0.6, 1.2
1–6/week 122 23 355 21 1.1 0.8,1.4 1.1 0.9, 1.5 1.2 0.8, 1.7 1.0 0.7, 1.5
C1/day 28 5 44 3 2.0 1.2, 3.2 2.0 1.2, 3.4 2.4 1.1, 5.0 1.7 0.8, 3.7
Trend-p 0.08 0.06 0.07 0.5
Candy without chocolate (1 pack)
\1/month 316 60 1,080 63 1.0 Ref 1.0 Ref 1.0 Ref 1.0 Ref
1–3/month 93 18 298 18 1.0 0.8, 1.4 1.1 0.8, 1.4 1.1 0.8, 1.6 1.0 0.7, 1.6
1–6/week 90 17 250 15 1.2 0.9, 1.6 1.1 0.8, 1.5 1.3 0.9, 1.9 0.9 0.6, 1.5
C1/day 27 5 73 4 1.1 0.7, 1.8 1.0 0.6, 1.6 1.5 0.8, 2.9 0.6 0.3, 1.3
Trend-p 0.2 0.5 0.09 0.3
Other mixed candy bar (1)
\1/month 276 52 1,041 61 1.0 Ref 1.0 Ref 1.0 Ref 1.0 Ref
1–3/month 119 23 382 22 1.1 0.9, 1.4 1.1 0.9, 1.4 1.4 1.0, 2.0 0.8 0.5, 1.2
1–6/week 109 21 253 15 1.4 1.1, 1.9 1.4 1.0, 1.8 1.5 1.1, 2.2 1.2 0.8, 1.9
C1/day 22 4 25 1 2.7 1.5, 4.9 2.2 1.2, 4.1 3.3 1.5, 7.3 1.0 0.3, 3.4
Trend-p 0.0004 0.005 0.001 0.7
a Adjusted for age, sex, and energy intake (kcal/day, men: quartiles, women: quartiles); ORs were not computed if cells had \5 observations
b Additionally adjusted for body mass index (\25.0, 25.0–29.9, C30 kg/m2), race (white, black/African American, Asian/Pacific Islander,
others), education (\ high-school graduate, high-school graduate, college, graduate work), smoking (never smoker, former cigarette smoker who
quit smoking[15 years ago, former cigarette smoker who quit smoking 1–15 years, current cigarette smoker or quit\1 year ago, pipe, and/or
cigar smoker), history of diabetes (yes, no) and physical activity (30-min moderate exercise each time: \1 month, 1–4/month, 2–6/week, and
daily); total sweets was additionally adjusted for quartiles of total red meat, white meat, vegetable and fruit, eggs, fish, dairy, whole grain, and
refined grain, and sweetened beverages (0, \1, and C1 serving per day)
Cancer Causes Control (2009) 20:835–846 839
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Table 3 Odds ratios (OR) and 95% confidence intervals (CI) for pancreatic cancer and daily servings of sweetened beverages in a population-
based case–control study, San Francisco Bay Area, California
Men ? Women Men Women
Sweetened beverages (1 serving = 1 can,
glass, bottle, or cup)
Case
n
% Control
n
% ORa 95% CIa ORb 95% CIb ORb 95% CIb ORb 95% CIb
All sweetened beverages/day
0 111 21 348 21 1.0 Ref. 1.0 Ref. 1.0 Ref. 1.0 Ref.
\1 249 47 942 55 0.8 0.6, 1.0 0.7 0.6, 1.0 1.0 0.6, 1.5 0.6 0.4, 0.9
C1 166 32 411 24 1.1 0.8, 1.5 1.0 0.7, 1.3 1.0 0.6, 1.7 1.0 0.6, 1.6
Trend-p 0.03 0.7 0.6 0.1
Total carbonated beverages/day
0 140 27 468 28 1.0 Ref. 1.0 Ref. 1.0 Ref. 1.0 Ref.
\1 242 46 894 53 0.9 0.7, 1.1 0.8 0.6, 1.0 1.0 0.7, 1.6 0.7 0.5, 1.0
C1 144 27 339 20 1.3 1.0, 1.7 1.1 0.8, 1.5 1.2 0.8, 2.0 1.1 0.7, 1.7
Trend-p 0.02 0.6 0.9 0.2
Total sugar-type carbonated beverages/day
0 284 54 961 57 1.0 Ref. 1.0 Ref. 1.0 Ref. 1.0 Ref.
\1 190 36 610 36 1.0 0.8, 1.2 1.0 0.8, 1.2 1.1 0.8, 1.5 0.8 0.6, 1.2
C1 52 10 130 8 1.1 0.8, 1.6 0.9 0.6, 1.3 0.9 0.5, 1.5 0.9 0.4, 1.8
Trend-p 0.3 0.4 0.3 0.9
Total sugar-free carbonated beverages/day
0 310 59 1,016 60 1.0 Ref. 1.0 Ref. 1.0 Ref. 1.0 Ref.
\1 124 24 487 29 0.8 0.7, 1.1 0.8 0.7, 1.1 1.2 0.8, 1.7 0.6 0.4, 1.0
C1 92 17 198 12 1.5 1.2, 2.1 1.5 1.1, 2.1 1.8 1.1, 2.8 1.4 0.9, 2.3
Trend-p 0.04 0.2 0.4 0.3
Coke, Pepsi, or other cola with sugar
\1/month 347 66 1,175 69 1.0 Ref. 1.0 Ref. 1.0 Ref. 1.0 Ref.
1–3/month 55 11 179 11 1.0 0.7, 1.4 1.0 0.7, 1.4 1.2 0.8, 1.8 0.8 0.5, 1.4
1–6/week 86 16 247 15 1.1 0.8, 1.4 1.1 0.8, 1.5 1.1 0.8, 1.7 1.0 0.6, 1.7
C1/day 38 7 100 6 1.1 0.7, 1.7 0.9 0.6, 1.4 0.9 0.5, 1.5 1.0 0.5, 2.1
Trend-p 0.6 0.99 0.9 0.9
Caffeine-free coke, Pepsi, or other cola with sugar
\1/month 497 94 1,598 94 1.0 Ref. 1.0 Ref. 1.0 Ref. 1.0 Ref.
1–3/month 13 2 55 3 0.8 0.4, 1.4 0.9 0.5, 1.6 0.9 0.4, 2.0 0.8 0.3, 2.4
1–6/week 15 3 37 2 1.1 0.6, 2.1 1.0 0.6, 2.0 1.4 0.7, 3.0 0.5 0.1, 1.9
C1/day 1 0.2 10 0.6 0.3 0.04, 2.3 0.3 0.04, 2.7 0.4 0.05, 2.3 NA NA
Trend-p 0.5 0.5 0.96 0.2
Other carbonated beverage with sugar
\1/month 364 69 1,229 72 1.0 Ref. 1.0 Ref. 1.0 Ref. 1.0 Ref.
1–3/month 67 13 200 12 1.1 0.8, 1.5 1.1 0.8, 1.5 1.2 0.8 1.8 0.8 0.5, 1.4
1–6/week 78 15 241 14 1.0 0.7, 1.3 1.0 0.7, 1.3 1.0 0.6, 1.4 1.1 0.7, 1.8
C1/day 17 3 31 2 1.6 0.8, 2.9 1.2 0.6, 2.2 1.4 0.6, 3.1 0.7 0.2, 2.3
Trend-p 0.5 0.8 0.7 0.8
Low calorie cola
\1/month 381 72 1,272 75 1.0 Ref. 1.0 Ref. 1.0 Ref. 1.0 Ref.
1–3/month 34 6 122 7 1.0 0.6, 1.4 1.0 0.7, 1.5 1.0 0.6, 1.8 1.0 0.5, 1.9
1–6/week 54 10 197 12 0.9 0.7, 1.3 0.9 0.7, 1.3 1.1 0.7, 1.7 0.8 0.4, 1.4
C1/day 57 11 110 6 1.8 1.2, 2.5 1.7 1.2, 2.4 1.8 1.1, 2.9 1.6 0.9, 2.8
Trend-p 0.04 0.06 0.06 0.4
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forms of candy were linked to greater risk of pancreatic
cancer among men, but inconsistently, or not related,
among women. The individual sweets that were positively
associated with pancreatic cancer risk included sweet
condiments, pure chocolate, and other mixed candy bars,
but not candy without chocolate. It is possible that satu-
rated fat intake may underlie several of these associations,
as we previously reported an increased risk of pancreatic
cancer for greater intake of total and saturated fat in this
population [20], and pure or mixed chocolate bars are high
in fat content. Furthermore, sweet condiments may often be
eaten on bread with butter, the latter of which was also
strongly positively associated with risk in our prior report
[20]. Furthermore, beverages with added sugar and tea-
spoons of sugar added to food were not linked to greater
risk, whereas some sugar-free sodas and low-calorie colas
were moderately positively related to risk among men.
Consistent with our hypotheses, other non- or low-calorie
beverages such as water, tea, or coffee were unassociated
with risk.
The positive association for sweets and pancreatic can-
cer risk among men but not women and the positive
association for low-calorie, but not sugar-sweetened, soft
drinks are somewhat inconsistent with prior reports,
although the literature is limited on this topic. Previous
cohort studies have reported associations for sweets and
pancreatic cancer risk among men and women combined,
or just among women. In the Swedish Mammography
Cohort, intake of sugar, soft drinks, and sweetened fruit
soups/stew were positively associated with 50–90%
increased risk among women [29]. In the Nurses Health
Study and Health Professionals Follow-up Study, soft
drinks were modestly positively associated with pancreatic
cancer risk among women, but not men [30]. In this two-
cohort analysis, non-cola diet soft drinks were also asso-
ciated with a 50% increase in risk of pancreatic cancer;
although confidence estimates included the null [30]. In a
distinct large cohort of men and women, fruit and fruit
juice intake, but not soda, was positively associated with
risk [31]. However, the authors commented that this likely
Table 3 continued
Men ? Women Men Women
Sweetened beverages (1 serving = 1 can,
glass, bottle, or cup)
Case
n
% Control
n
% ORa 95% CIa ORb 95% CIb ORb 95% CIb ORb 95% CIb
Low calorie caffeine-free cola
\1/month 437 83 1,394 82 1.0 Ref. 1.0 Ref. 1.0 Ref. 1.0 Ref.
1–3/month 24 5 83 5 1.0 0.6, 1.6 1.0 0.6, 1.6 1.1 0.5, 2.2 0.9 0.5, 1.8
1–6/week 43 8 171 10 0.8 0.6, 1.1 0.8 0.5, 1.1 0.9 0.5, 1.4 0.7 0.4, 1.3
C1/day 22 4 51 3 1.4 0.8, 2.4 1.1 0.7, 2.0 1.1 0.5, 2.5 1.3 0.6, 2.7
Trend-p 0.96 0.6 0.9 0.7
Other low calorie carbonated beverage
\1/month 418 79 1,366 80 1.0 Ref. 1.0 Ref. 1.0 Ref. 1.0 Ref.
1–3/month 40 8 128 8 1.0 0.7, 1.5 1.0 0.7, 1.5 1.5 0.9, 2.5 0.7 0.4, 1.3
1–6/week 47 9 167 10 0.9 0.6, 1.2 0.9 0.6, 1.2 1.0 0.6, 1.6 0.6 0.4, 1.2
C1/day 21 4 39 2 1.6 0.9, 2.8 1.4 0.8, 2.5 1.8 0.8, 3.8 1.2 0.4, 3.2
Trend-p 0.6 0.97 0.2 0.2
Hawaii punch, lemonade, or other non-carbonated fruit drinks
\1/month 359 68 1,075 63 1.0 Ref. 1.0 Ref. 1.0 Ref. 1.0 Ref.
1–3/month 71 14 286 17 0.7 0.5, 1.0 0.7 0.5, 1.0 0.7 0.5, 1.1 0.7 0.5, 1.2
1–6/week 75 14 292 17 0.7 0.5, 0.9 0.7 0.5, 0.9 0.8 0.5, 1.2 0.5 0.3, 0.9
C1/day 21 4 48 3 1.1 0.6, 1.9 1.0 0.6, 1.8 0.4 0.2, 1.1 2.0 1.0, 4.2
Trend-p 0.03 0.03 0.06 0.4
a Adjusted for age, sex, and energy intake (kcal/day, men: quartiles, women: quartiles)
b Additionally adjusted for body mass index (\25.0, 25.0–29.9, C30 kg/m2), race (white, black/African American, Asian/Pacific Islander,
others), education (\high-school graduate, high-school graduate, 1–4 years college, graduate school), smoking (never smoker, former cigarette
smoker who had quit smoking [15 years previously, former cigarette smoker who had quit smoking 1–15 years previously, current cigarette
smoker or former cigarette smoker who had quit smoking \1 year previously, pipe and/or cigar smoker), history of diabetes (yes, no), and
physical activity (30-min moderate exercise each time: \1 month, 1–4/month, 2–6/week, and daily); Additionally, all sweetened beverages,
sugar-type carbonated beverages, and sugar-free carbonated beverages were adjusted for quartiles of red meat, white meat, vegetable and fruit,
eggs, fish, dairy, whole grain, and refined grain, and sweets (0, \1, and C1 serving per day), and were mutually adjusted for each other
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reflected an overall positive association for fructose/sugars
that were strongly correlated with fruits and juices, and that
there may have been measurement error in the assessment
of sodas. In contrast, the large prospective National Insti-
tutes of Health (NIH)–AARP Diet and Health Study
reported no association for high intake of total added sugar,
sugar-sweetened foods and beverages, or diet soft drinks
and pancreatic cancer [32].
The trend toward stronger associations for sweets being
more common among those who were obese or exercised
infrequently is consistent with results from the Nurses
Health Study, where positive associations for sweetened
soft-drink intake [30] and fructose [33] and pancreatic
cancer risk were stronger among women with a high BMI
or who exercised less. Similarly, in the NIH–AARP cohort,
there were suggestive (but not always statistically signifi-
cant) positive trends for total added sugar and pancreatic
cancer risk only among those who were obese or less fre-
quent exercisers [32].
Data from case–control studies are also limited, but one
previous case–control study reported a non-statistically
significant 50% increased risk for sweet foods [34], while
another observed a statistically significant 80% elevation in
risk associated with dessert intake among women and no
association among men [35]. In contrast to our results, an
early case–control study that examined a wide range of
individual dietary factors reported an inverse association
for consumption of diet soda and risk of pancreatic cancer
[36]. It is possible that comparison of these early results
with our study is inappropriate given the dramatic changes
in diet soda consumption patterns over the last several
decades.
Another way to examine the impact of sweets on pan-
creatic cancer risk has been to examine intake of different
sugars. Similar to our study, four case–control studies and
one cohort have reported no association for simple sugars
[35, 37] or sucrose consumption [37–40]; although two of
these reported statistically significant doubling to tripling
of risk for added or refined sugar intake [38, 40]. Poly-
saccharides but not mono- or disaccharides were related to
a 2.6-fold increase in risk in a case–control study [34]. In
contrast to our findings, in the large Hawaii-Los Angeles
Table 4 Odds ratios (OR) and 95% confidence intervals (CI) for pancreatic cancer and intake of fructose, sucrose, lactose in a population-based
case–control study, San Francisco Bay Area, California
Men ? Women Men Women
Quartiles Case n % Control n % ORa 95% CIa ORb 95% CIb ORb 95% CIb ORb 95% CIb
Fructose, gm/day
Quartile 1 160 30 426 25 1.0 Referent 1.0 Referent 1.0 Referent 1.0 Referent
Quartile 2 129 25 424 25 0.8 0.6–1.1 0.9 0.7–1.2 1.0 0.7–1.4 0.8 0.5–1.2
Quartile 3 124 24 425 25 0.8 0.6–1.0 0.9 0.7–1.2 0.8 0.6–1.2 0.9 0.6–1.4
Quartile 4 112 21 426 25 0.7 0.5–0.9 0.8 0.6–1.1 0.8 0.5–1.1 0.9 0.6–1.3
Trend-p 0.01 0.2 0.05 0.9
Sucrose, gm/day
Quartile 1 141 27 425 25 1.0 Referent 1.0 Referent 1.0 Referent 1.0 Referent
Quartile 2 125 24 425 25 0.9 0.7–1.2 1.0 0.8–1.4 1.1 0.8–1.7 0.9 0.6–1.5
Quartile 3 121 23 425 25 0.9 0.7–1.2 1.0 0.7–1.3 1.0 0.7–1.5 1.2 0.8–1.8
Quartile 4 138 26 426 25 1.0 0.8–1.3 1.0 0.8–1.4 1.0 0.7–1.5 1.1 0.7–1.7
Trend-p 1.0 0.9 1.0 0.6
Lactosec, gm/day
Quartile 1 94 18 425 25 1.0 Referent 1.0 Referent 1.0 Referent 1.0 Referent
Quartile 2 136 26 425 25 1.5 1.1–2.0 1.5 1.1–2.0 1.6 1.1–2.7 1.2 0.7–1.9
Quartile 3 131 25 425 25 1.4 1.1–1.9 1.6 1.2–2.1 1.8 1.2–2.8 2.0 1.3–3.1
Quartile 4 164 31 425 25 1.8 1.3–2.4 2.0 1.5–2.7 2.1 1.3–3.0 1.7 1.1–2.7
Trend-p 0.0003 \0.0001 0.003 0.03
a Used energy residual model; adjusted for age, sex, and energy intake (kcal/day, men: quartiles, women: quartiles)
b Additionally adjusted for body mass index (\25.0, 25.0–29.9, C30 kg/m2), race (white, black/African American, Asian/Pacific Islander,
others), education (\high-school graduate, high-school graduate, 1–4 years college, graduate school), smoking (never smoker, former cigarette
smoker who had quit smoking [15 years previously, former cigarette smoker who had quit smoking 1–15 years previously, current cigarette
smoker or former cigarette smoker who had quit smoking \1 year previously, pipe and/or cigar smoker), history of diabetes (yes, no), and
physical activity (30-min moderate exercise each time: \1 month, 1–4/month, 2–6/week, and daily)
c Additionally adjusted for total fat consumption by quartiles
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Multiethnic Cohort, risk increased with greater intake of
total sugars, fructose, and sucrose, and was statistically
significant for fructose (relative risk = 1.4; 95% CI: 1.0,
1.8; for highest vs. lowest quartiles) [31]. In the Nurses
Health Study, fructose was positively associated with
pancreatic cancer risk among overweight women with low
physical activity levels (fructose relative risk = 3.2, 95%
CI: 1.1, 8.9 when comparing extreme quartiles).
Lactose is a sugar naturally occurring in milk and milk
products, and there are very limited prior reports on lactose
and pancreatic cancer. Baghurst et al. observed no associ-
ation for lactose and risk of pancreatic cancer in an earlier
case–control study [38]. Milk and dairy intake have not been
consistently associated with pancreatic cancer [41], with
most studies reporting null associations [34, 35, 40–47], and
only a few observing positive [20, 48] or inverse associa-
tions [49]. In a study of cases only, Morales et al. reported
that daily versus non-daily intake of dairy products, but not
other food groups, was associated with a five-fold greater
occurrence of K-Ras mutated pancreatic tumors, and K-ras
mutations are considered to be an early event in pancreatic
carcinogenesis [50]. We observed a positive association for
lactose and pancreatic cancer risk, independent of total
energy and fat; consistent with and expanding on the pre-
viously reported positive association for dairy products and
pancreatic cancer risk in this population [20],
The observed null results for coffee and pancreatic
cancer risk were consistent with several previous studies
[36, 42, 48, 49, 51–54]. The slightly elevated risk for non-
herbal tea among men in our study may be due to chance,
and was contrary to several other null reports [36, 42, 53].
We did not directly examine sweetened tea or coffee;
however, teaspoons of added sugar to foods or beverages
and artificial sweeteners were unassociated with risk.
Simple carbohydrates (e.g., sugars) raise blood glucose
levels more than starches and other macronutrients [55, 56].
Chronic high intake of sweets may increase pancreatic can-
cer risk by affecting glucose metabolism and predisposing to
hyperglycemia, insulin insensitivity, and hyperinsulinemia.
Glycemic load and index are measures of the body’s glucose-
response (or insulin demand) to carbohydrate intake. Six
cohort studies examining estimated glycemic load or index
from self-reported questionnaires and pancreatic cancer risk
observed no associations [31, 37, 57–59], while the Nurses
Health Study reported that glycemic load was strongly
related to risk among overweight or sedentary women [33].
In contrast, prospective studies have linked higher cir-
culating fasting glucose [4–7] and insulin levels [4] to future
risk of pancreatic cancer many years later. The Chicago
Heart Association Detection Project, with an average of
25 years of follow-up examined fasting glucose and pan-
creatic cancer mortality. Their results for fasting glucose and
risk of pancreatic cancer were similar even when they
excluded cases that occurred within the first five years of
follow-up [5]. In the Alpha Tocopherol Beta-Carotene
Cancer Prevention trial, associations for fasting glucose and
pancreatic cancer were stronger when limited only to those
participants with more than 10 years of follow-up [4]. Taken
together, these studies support a positive dose-dependent
relationship between hyperglycemia and pancreatic cancer
incidence or mortality. The lack of consistent association
between sweet foods or sweetened beverages and pancreatic
cancer risk in this study may in part be due to the variable
effects of sugar intake on glucose metabolism, depending on
sugar type, fiber, protein, fat and starch composition, tem-
perature, cooking, and processing of the food [55].
We cannot exclude the possibility of chance to explain
some of our results. The elevated risk observed in the
current study for total and specific sweets, in particular
among those who exercised less, had a high BMI, or
smoked, provides some support for the hypothesis that
sweets intake plus lifestyle factors combined may predis-
pose to impaired glucose tolerance that can subsequently
influence pancreatic cancer risk. Impaired glucose toler-
ance is positively correlated with high glucose intake,
obesity, sedentary habits, and smoking [33, 60–62]. The
elevated risks associated with diet soda intake, in particular
among men, those who were obese, did not have diabetes,
or who were smokers, could possibly be due to residual
confounding by other unmeasured diet and lifestyle factors.
This study had several possible limitations that must be
considered. Recall bias may have affected the results,
although, when this study was conducted little was known
about dietary risk factors for pancreatic cancer. Non-dif-
ferential measurement error in assessment of the dietary
exposures could have led to a bias toward the null, although
prior publications from this population reported positive
associations for specific meats and fats, and inverse asso-
ciations for fruit and vegetable intake, consistent with other
cohort and case–control studies [11, 20, 41]. We were
unable to examine the effects of glycemic load or index or
pre-diagnostic circulating glucose on risk of pancreatic
cancer in this study. There was a 67% response rate among
eligible cases and controls. It is possible that eligible control
subjects who chose to participate were those who tended to
be more health conscious and thus different than the popu-
lation that gave rise to the cases. There is also the possibility
of survivor bias, whereby those cases who did not survive
long enough to be interviewed may have differed mean-
ingfully in their diets compared to those who were included.
Strengths of this study include the population-based
design, large sample size, detailed validated dietary ques-
tionnaire completed using only direct in-person interviews,
and no proxy interviews. We interviewed participants about
dietary practices one year before their cancer diagnosis or
interview for controls to avoid recent assessment of dietary
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changes due to pancreatic cancer. The refusal rate was low
at 8%, and the primary reason we lost patients was the rapid
mortality rate. In conclusion, these data provide limited
evidence for our original hypotheses that sweets, sugars,
and sweetened beverages increase the risk of pancreatic
cancer. The stronger associations stratified by sex, BMI,
exercise, diabetes status, and smoking were intriguing and
warrant further research.
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